Jane Sayi

Jane Sayi

UNVERIFIED PROFILE

Are you Jane Sayi?   Register this Author

Register author
Jane Sayi

Jane Sayi

Publications by authors named "Jane Sayi"

Are you Jane Sayi?   Register this Author

10Publications

183Reads

34Profile Views

4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians.

Pharmacogenet Genomics 2008 Mar;18(3):201-8

Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3282f50ee9DOI Listing
March 2008

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population.

Pharmacogenet Genomics 2006 Sep;16(9):637-45

Department of Clinical Toxicology, Central Laboratories & Blood Bank, King Fahad Medical City, Riyadh 11525, Kingdom of Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.fpc.0000230411.89973.1bDOI Listing
September 2006

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles.

Biochem Biophys Res Commun 2005 Dec 13;338(1):299-305. Epub 2005 Sep 13.

Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2005.09.020DOI Listing
December 2005

Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.

Eur J Clin Pharmacol 2005 Nov 29;61(10):755-61. Epub 2005 Oct 29.

African Institute of Biomedical Science & Technology (AIBST), P.O. Box 2294, Harare, Zimbabwe.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-005-0037-3DOI Listing
November 2005

Frequency of -163 C>A and 63 C>G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations.

Clin Chem Lab Med 2004 ;42(8):939-41

Drug Metabolism Group, Department of Biochemistry, University of Zimbabwe, Harare, Zimbabwe.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2004.152DOI Listing
February 2005

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.

Eur J Clin Pharmacol 2002 Nov 1;58(8):555-8. Epub 2002 Nov 1.

Department of Medical Laboratory Sciences and Technology, Division of Clinical Pharmacology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sewden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-002-0518-6DOI Listing
November 2002

The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.

Clin Pharmacol Ther 2002 Jan;71(1):77-88

Division of Clinical Pharmacology, Department of Medical Laboratory Sciences and Technology, Karolinska Institutet at Huddinge University Hospital, Stockholm.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mcp.2002.120239DOI Listing
January 2002